Tolera Therapeutics Obtains $250,000 New Round

  • Feed Type
  • Date
    9/17/2014
  • Company Name
    Tolera Therapeutics
  • Mailing Address
    P.O. Box 970 Portage, MI 49081 USA
  • Company Description
    Building upon research done at the University of Kentucky and the Cleveland Clinic, Tolera Therapeutics is developing and commercializing therapies for the immune suppression / modulation market with the goal of addressing unmet medical needs with safer, more targeted solutions to reduce the risk of serious and toxic side effects.
  • Website
    http://www.tolera.com
  • Transaction Type
    Debt
  • Transaction Amount
    $250,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor